TFS Capital’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

TFS Capital’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,061	Closed	-$32K	–	1352
2016 Q1	$32K	Sell	3,061 -87,901	-97%	-$1.75M	﹤0.01%	963
2015 Q4	$2.68M	Sell	90,962 -40,345	-31%	-$1.22M	0.29%	103
2015 Q3	$4.15M	Buy	131,307 +128,980	+5,543%	+$6.17M	0.4%	40
2015 Q2	$138K	Sell	2,327 -16,034	-87%	-$1.13M	0.01%	789
2015 Q1	$1.96M	Buy	+18,361	New	+$1.75M	0.19%	141
2014 Q4	–	Sell	-9,542	Closed	-$733K	–	1295
2014 Q3	$733K	Sell	9,542 -30,325	-76%	-$2.39M	0.06%	469
2014 Q2	$3.58M	Buy	39,867 +19,803	+99%	+$1.21M	0.28%	74
2014 Q1	$1.07M	Buy	+20,064	New	+$662K	0.07%	431

Other funds holding PTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

TFS Capital's PTX Position: Q2 2016 in Review

TFS Capital sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 3,061 shares — an estimated $32K sold.

TFS Capital first reported a position in PTX in Q1 2014 and held it in 8 quarters. The position peaked at $4.15M in Q3 2015. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

TFS Capital reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
TFS Capital sold 3,061 Pernix Therapeutics Holdings, Inc. shares in Q2 2016, an estimated $32K.
TFS Capital first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2014 and held it in 8 quarters.
TFS Capital's Pernix Therapeutics Holdings, Inc. position peaked at $4.15M in Q3 2015.
56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on TFS Capital's 13F filing for Q2 2016, filed 11 Aug 2016.